Next Oncology is occupying space in the Texas Medical Center to conduct cancer-fighting clinical trials in Houston.

Toxicity information from phase 3 oncology clinical trials often is incomplete and interpreted in ways that minimize its ...

Texas Children's Hospital and The University of Texas MD Anderson Cancer Center have announced a collaboration dedicated to ...

Aprea Therapeutics has dosed a subject with human papillomavirus (HPV)-positive head and neck squamous cell carcinoma (HNSCC) ...

Follicular lymphoma is an indolent malignancy with a generally favorable prognosis, with survival often measured in decades.

HPV driven cancers, including HPV+ HNSCC, are characterized by defects in the DDR pathway, making them potentially susceptible to WEE1 inhibition. HPV+ cancers are those where the underlying cause is ...

These two general immune response findings, immune response at baseline and increasing immune response over time, were also observed in the Phase IIb clinical trial for HLA-A*02 only patients. These ...

Surgery may not be the best next course of treatment for patients with early-stage breast cancer who had a complete response ...

MONDAY, March 31, 2025 (HealthDay News) -- Surgery might not be needed to treat as many as 60% of early-stage breast cancers, ...

A 2012 study of patients with low-tumor-burden follicular lymphoma showed that the 4-year freedom from treatment failure rate ...

Durability Results from BOND-003 data will be presented as a late breaker as part of AUA’s Practice-changing, Paradigm-shifting Clinical Trials in Urology - - Additional updates from across CG ...

I’m Danielle Anderson, a Licensed Clinical Social Worker with over a decade of experience helping adults navigate challenges such as depression, anxiety, grief, trauma, chronic illness ...